Email
Print
Prostate Cancer Medicine Market - Forecast(2024 - 2030)
1. Prostate Cancer Medicine Market - Overview
1.1 Definitions and Scope
2. Prostate Cancer Medicine Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Prostate Cancer Medicine Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Prostate Cancer Medicine Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Prostate Cancer Medicine Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Prostate Cancer Medicine Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Prostate Cancer Medicine Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Prostate Cancer Medicine Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Prostate Cancer Medicine Market - By Drug Type (Market Size -$Million / $Billion)
9.1 Hormonal Therapy Drug
9.1.1 Lhrh Antagonist
9.1.2 Lhrh Analog
9.1.3 Antiandrogens
9.1.4 Pipeline Drug For Hormonal Therapy
9.2 Chemotherapy Drug
9.2.1 Off Patent Drug
9.2.2 Patented Drug
9.3 Immunotherapy Drug
9.4 Target Therapy Drug
9.4.1 Angiogenesis Inhibitor
9.4.2 Apoptosis Inducing
9.4.3 Signal Transduction Inhibitor
10. Prostate Cancer Medicine - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Prostate Cancer Medicine- By Geography (Market Size -$Million / $Billion)
11.1 Prostate Cancer Medicine Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Prostate Cancer Medicine- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Prostate Cancer Medicine- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Prostate Cancer Medicine - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Prostate Cancer Medicine - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Prostate Cancer Medicine Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Prostate Cancer Medicine Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Prostate Cancer Medicine Market - Key Company List by Country Premium
15. Prostate Cancer Medicine Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 Active Biotech
15.4 Astellas Pharma Inc
15.5 Astrazeneca Plc
15.6 Bayer Ag
15.7 Bristol Myers-Squibb
15.8 Johnson Johnson
15.9 Pfizer Inc
15.10 Roche Holding Ag
15.11 Teva Pharmaceutical Industry Ltd
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Prostate Cancer Medicine Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Prostate Cancer Medicine Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Prostate Cancer Medicine Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Prostate Cancer Medicine Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Prostate Cancer Medicine Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Prostate Cancer Medicine Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Prostate Cancer Medicine Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Prostate Cancer Medicine Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Prostate Cancer Medicine Market - By Drug Type (Market Size -$Million / $Billion)
9.1 Hormonal Therapy Drug
9.1.1 Lhrh Antagonist
9.1.2 Lhrh Analog
9.1.3 Antiandrogens
9.1.4 Pipeline Drug For Hormonal Therapy
9.2 Chemotherapy Drug
9.2.1 Off Patent Drug
9.2.2 Patented Drug
9.3 Immunotherapy Drug
9.4 Target Therapy Drug
9.4.1 Angiogenesis Inhibitor
9.4.2 Apoptosis Inducing
9.4.3 Signal Transduction Inhibitor
10. Prostate Cancer Medicine - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Prostate Cancer Medicine- By Geography (Market Size -$Million / $Billion)
11.1 Prostate Cancer Medicine Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Prostate Cancer Medicine- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Prostate Cancer Medicine- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Prostate Cancer Medicine - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Prostate Cancer Medicine - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Prostate Cancer Medicine Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Prostate Cancer Medicine Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Prostate Cancer Medicine Market - Key Company List by Country Premium
15. Prostate Cancer Medicine Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 Active Biotech
15.4 Astellas Pharma Inc
15.5 Astrazeneca Plc
15.6 Bayer Ag
15.7 Bristol Myers-Squibb
15.8 Johnson Johnson
15.9 Pfizer Inc
15.10 Roche Holding Ag
15.11 Teva Pharmaceutical Industry Ltd
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Prostate Cancer Medicine Market - Appendix16.1 Abbreviations
16.2 Sources
17. Prostate Cancer Medicine Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 ($M)1.1 Hormonal Therapy Drug Market 2023-2030 ($M) - Global Industry Research
1.1.1 Lhrh Antagonist Market 2023-2030 ($M)
1.1.2 Lhrh Analog Market 2023-2030 ($M)
1.1.3 Antiandrogens Market 2023-2030 ($M)
1.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 ($M)
1.4 Target Therapy Drug Market 2023-2030 ($M) - Global Industry Research
1.4.1 Angiogenesis Inhibitor Market 2023-2030 ($M)
1.4.2 Apoptosis Inducing Market 2023-2030 ($M)
1.4.3 Signal Transduction Inhibitor Market 2023-2030 ($M)
2.Global Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 (Volume/Units)
2.1 Hormonal Therapy Drug Market 2023-2030 (Volume/Units) - Global Industry Research
2.1.1 Lhrh Antagonist Market 2023-2030 (Volume/Units)
2.1.2 Lhrh Analog Market 2023-2030 (Volume/Units)
2.1.3 Antiandrogens Market 2023-2030 (Volume/Units)
2.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 (Volume/Units)
2.4 Target Therapy Drug Market 2023-2030 (Volume/Units) - Global Industry Research
2.4.1 Angiogenesis Inhibitor Market 2023-2030 (Volume/Units)
2.4.2 Apoptosis Inducing Market 2023-2030 (Volume/Units)
2.4.3 Signal Transduction Inhibitor Market 2023-2030 (Volume/Units)
3.North America Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 ($M)
3.1 Hormonal Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
3.1.1 Lhrh Antagonist Market 2023-2030 ($M)
3.1.2 Lhrh Analog Market 2023-2030 ($M)
3.1.3 Antiandrogens Market 2023-2030 ($M)
3.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 ($M)
3.4 Target Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
3.4.1 Angiogenesis Inhibitor Market 2023-2030 ($M)
3.4.2 Apoptosis Inducing Market 2023-2030 ($M)
3.4.3 Signal Transduction Inhibitor Market 2023-2030 ($M)
4.South America Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 ($M)
4.1 Hormonal Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
4.1.1 Lhrh Antagonist Market 2023-2030 ($M)
4.1.2 Lhrh Analog Market 2023-2030 ($M)
4.1.3 Antiandrogens Market 2023-2030 ($M)
4.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 ($M)
4.4 Target Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
4.4.1 Angiogenesis Inhibitor Market 2023-2030 ($M)
4.4.2 Apoptosis Inducing Market 2023-2030 ($M)
4.4.3 Signal Transduction Inhibitor Market 2023-2030 ($M)
5.Europe Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 ($M)
5.1 Hormonal Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Lhrh Antagonist Market 2023-2030 ($M)
5.1.2 Lhrh Analog Market 2023-2030 ($M)
5.1.3 Antiandrogens Market 2023-2030 ($M)
5.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 ($M)
5.4 Target Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
5.4.1 Angiogenesis Inhibitor Market 2023-2030 ($M)
5.4.2 Apoptosis Inducing Market 2023-2030 ($M)
5.4.3 Signal Transduction Inhibitor Market 2023-2030 ($M)
6.APAC Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 ($M)
6.1 Hormonal Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Lhrh Antagonist Market 2023-2030 ($M)
6.1.2 Lhrh Analog Market 2023-2030 ($M)
6.1.3 Antiandrogens Market 2023-2030 ($M)
6.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 ($M)
6.4 Target Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
6.4.1 Angiogenesis Inhibitor Market 2023-2030 ($M)
6.4.2 Apoptosis Inducing Market 2023-2030 ($M)
6.4.3 Signal Transduction Inhibitor Market 2023-2030 ($M)
7.MENA Prostate Cancer Medicine Market, By Drug Type Market 2023-2030 ($M)
7.1 Hormonal Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Lhrh Antagonist Market 2023-2030 ($M)
7.1.2 Lhrh Analog Market 2023-2030 ($M)
7.1.3 Antiandrogens Market 2023-2030 ($M)
7.1.4 Pipeline Drug For Hormonal Therapy Market 2023-2030 ($M)
7.4 Target Therapy Drug Market 2023-2030 ($M) - Regional Industry Research
7.4.1 Angiogenesis Inhibitor Market 2023-2030 ($M)
7.4.2 Apoptosis Inducing Market 2023-2030 ($M)
7.4.3 Signal Transduction Inhibitor Market 2023-2030 ($M)
LIST OF FIGURES
1.US Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)2.Canada Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
3.Mexico Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
4.Brazil Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
5.Argentina Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
6.Peru Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
7.Colombia Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
8.Chile Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
9.Rest of South America Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
10.UK Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
11.Germany Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
12.France Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
13.Italy Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
14.Spain Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
15.Rest of Europe Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
16.China Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
17.India Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
18.Japan Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
19.South Korea Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
20.South Africa Prostate Cancer Medicine Market Revenue, 2023-2030 ($M)
21.North America Prostate Cancer Medicine By Application
22.South America Prostate Cancer Medicine By Application
23.Europe Prostate Cancer Medicine By Application
24.APAC Prostate Cancer Medicine By Application
25.MENA Prostate Cancer Medicine By Application
26.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Active Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bristol Myers-Squibb, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Bayer Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Astellas Pharma Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Roche Holding Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)